Канал: Mesowatch - Mesothelioma & Asbsestos Exposure News

Arizona Veterans: The Persistent Danger of Asbestos Exposure | Protect Your Health

Arizona Veterans: The Persistent Danger of Asbestos Exposure | Protect Your Health

FDA Clears AI-Discovered Drug for Mesothelioma Treatment | Groundbreaking News

FDA Clears AI-Discovered Drug for Mesothelioma Treatment | Groundbreaking News

The Asbestos Lawsuit Process: From Diagnosis to Legal Action Explained

The Asbestos Lawsuit Process: From Diagnosis to Legal Action Explained

Talcum Powder Linked to Lung Cancer | $63.4M Verdict Explained – Your Right to Compensation

Talcum Powder Linked to Lung Cancer | $63.4M Verdict Explained – Your Right to Compensation

Is Johnson & Johnson Playing Fair? Inside the $1.1 Billion Talc Settlement Dispute

Is Johnson & Johnson Playing Fair? Inside the $1.1 Billion Talc Settlement Dispute

Navigating Asbestos Claims: Insights from Leading Experts Dr. Patti Shelton & Chris Placitella

Navigating Asbestos Claims: Insights from Leading Experts Dr. Patti Shelton & Chris Placitella

The End of Asbestos: EPA's Historic Ban and Its Implications 🚫

The End of Asbestos: EPA's Historic Ban and Its Implications 🚫

Johnson & Johnson Hit with $63.4 Million Verdict in Groundbreaking Talc Lung Cancer Case

Johnson & Johnson Hit with $63.4 Million Verdict in Groundbreaking Talc Lung Cancer Case

Rising Mesothelioma Cases in Senior Women: Two Decades of Concern

Rising Mesothelioma Cases in Senior Women: Two Decades of Concern

Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit

Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit

Examining the Proposed ECBA Bill to Curb J&J's Bankruptcy Maneuver

Examining the Proposed ECBA Bill to Curb J&J's Bankruptcy Maneuver

Johnson & Johnson’s Bankruptcy Plan Rejected by Appellate Court

Johnson & Johnson’s Bankruptcy Plan Rejected by Appellate Court

Understanding J&J's $505 Million Settlement With Talc Suppliers from Mesowatch

Understanding J&J's $505 Million Settlement With Talc Suppliers from Mesowatch

Montana Asbestos Spill: $8M Verdict Against Railway for Deaths from Mesowatch

Montana Asbestos Spill: $8M Verdict Against Railway for Deaths from Mesowatch

Judge Dismisses Bid to Block J&J's $6.48B Talc Settlement: What's Next? from Mesowatch

Judge Dismisses Bid to Block J&J's $6.48B Talc Settlement: What's Next? from Mesowatch

Class Action Lawsuit: Women at Risk from J&J Talc Powder Products from Mesowatch

Class Action Lawsuit: Women at Risk from J&J Talc Powder Products from Mesowatch

Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case from Mesowatch

Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case from Mesowatch

EPA’s Asbestos Ban: Not Enough to End Cancer for Workers from Mesowatch

EPA’s Asbestos Ban: Not Enough to End Cancer for Workers from Mesowatch

Historic Victory: EPA Seals the Fate of Asbestos in America from Mesowatch

Historic Victory: EPA Seals the Fate of Asbestos in America from Mesowatch

Mesothelioma Survival Study Finds: Lung-Sparing Surgery is Key from Mesowatch

Mesothelioma Survival Study Finds: Lung-Sparing Surgery is Key from Mesowatch

WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns from Mesowatch

WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns from Mesowatch

The Power of Immunotherapy: A Promising Case for Peritoneal Mesothelioma from Mesowatch

The Power of Immunotherapy: A Promising Case for Peritoneal Mesothelioma from Mesowatch

Study Finds Cancer Link in Talc, Pressuring J&J’s $6.5 Billion Settlement Plan from Mesowatch

Study Finds Cancer Link in Talc, Pressuring J&J’s $6.5 Billion Settlement Plan from Mesowatch